First Brazilian Series of Urologic Surgeries Using Versius Robotic Multiport Platform.

PURPOSE: This is the first series of urological conditions using the Versius Surgical System® platform in Brazil. We evaluated perioperative results, and surgeons' learning curve in Brazilian hospitals. MATERIALS AND METHODS: This prospective, multicenter study included urological surgeons certified on the Versius® platform and their respective procedures from May 2022 to August 2024. Perioperative variables included type of surgery, docking time, console time, number of bedside units (BSUs), complications according to the Clavien-Dindo classification, readmission and reoperation rates within 30 days after surgery. Surgeons were stratified according to experience in laparoscopy and robotic surgery. RESULTS: Nineteen surgeons and 302 urological procedures were included. There was no statistically significant difference between docking time and console time when comparing obese patients (BMI > 30, p=0.507) and non-obese patients (BMI < 30, p=0.733). One hundred thirty-seven (45.4%) surgeries were performed by surgeons with experience in laparoscopy and robotics (> 5 years), and 238 surgeries (78.8%) were performed by surgeons who had more than 10 Versius® procedures. Docking time was 13.4 (SD 7.23) minutes. Nephroureterectomy was the procedure with the shortest docking (8.7 minutes, 6-13 min) and console (83.3 minutes, 38-152 min) times. Of the 10 surgeons with 10 or more procedures, 6 had shorter docking times, and 4 had shorter console times. There were four Clavien-Dindo III-IV complications within 30 days postoperatively (1.3%), and six (2%) patients required reoperation. Mean hospital stay was 2 days. CONCLUSION: This study is the largest Brazilian and worldwide case series of urological surgeries performed using the Versius® robotic platform. Our results demonstrate the safety and efficacy of the Versius® platform and provide real-world evidence of the surgeons' learning curves and performance based on their prior expertise in laparoscopic and/or robotic surgery.